Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial

por Penson, Richard T., Valencia, Ricardo Villalobos, Cibula, David, Colombo, Nicoletta, Leath, Charles A., Bidziński, Mariusz, Kim, Jae-Weon, Nam, Joo Hyun, Madry, Radoslaw, Hernández, Carlos, Mora, Paulo A.R., Ryu, Sang Young, Milenkova, Tsveta, Lowe, Elizabeth S., Barker, Laura, Scambia, Giovanni
Publicado 2020